ABOUT US PRESS OUR WEBSITES Life Science The most creative life science hub in Europe If you’re looking for promising commercial life science projects or cross-disciplinary research partnerships, you need to look at the Stockholm-Uppsala region. It is Scandinavia’s leading life science cluster and one of the world’s most productive. On average, an astounding 15-20 new life science companies were formed in the region each year during the last decade. The close ties between industry, academia, society and healthcare ease the development of ideas into commercially viable products. Five of Europe’s finest academic institutions, among them Karolinska Institutet, home of the Nobel assembly, play their part too. Add the large medical databases and the basic principle in Sweden that the individual researcher owns the result of his or her research and you get the perfect conditions for new and profitable ventures. Our advice is to get in early! Ylva Hultman-Erlandsson Business Development Manager Phone: +46 (0)8-508 280 65 Mobile: +46 (0)70-472 80 65 ylva.hultman@stockholm.se Key Investment Opportunities Digital Health In Stockholm, the most creative minds from health care, life sciences, ICT and gaming are shaping a new generation of digital solutions with the potential to transform health care on a global scale. The needs are enormous and Stockholm is the hub for Digital Health innovation. Science for Life Laboratory The aim of SciLifeLab is to be an internationally leading centre that develops and provides access to advanced technologies for molecular biosciences. The centre has played an important part in significant breakthroughs, such as the so-called Human Protein Atlas. Neuroscience Stockholm-Uppsala's neuroscience focus covers a broad spectrum of research with hundreds of scientists working on promising projects. Among them the Karolinska Institute’s Bengt Winblad who has been ranked as the world’s most prolific researcher in the Alzheimer field. Stem cell Research with all types of stem cells has been possible in Sweden since 2002 thanks to legislation that strongly promotes science and development. A large part of this research takes place in the Stockholm-Uppsala region, which has now reached a critical mass of researchers and tech companies. Metabolic Diseases The majority of the initiatives in the metabolic diseases field in the Stockholm-Uppsala region are directed towards diabetes, and in some cases obesity. Examples of on-going projects are the development of a diabetes vaccine and transplantation of insulin producing cells. Cancer Karolinska Institutet is ranked as number one in Europe when it comes to cancer research and all the top 20 pharmaceutical companies are investing in the region. Major improvements in the treatment of breast cancer are among the recent successes. Health Tech Report Business opportunities in Stockholm-Uppsala Investment opportunities in digital health One fourth of the investable companies on the Life Science Hotlist represents the digital health sector. Innovation that saves lives The Pacemaker, a medical device that uses electrical impulses to regulate the beating of the heart, was invented in Stockholm in 1958. One of the largest stem cell banks Stockholm has one of the world´s largest stem cell banks, consisting of 70 stem cell lines. Infectious Diseases Report World-Leading Research and Business Opportunities in the Stockholm-Uppsala Region Stay informed! In focus 8 reasons companies like Amazon chose Stockholm By now you may have heard that Sweden is the best country in the world to do business in. It's a statement backed up by plenty of data and rankings on innovation, taxes, technology, and so much more. And Stockholm, the capital, is the hub of it all. Investments in Stockholm hit new record highs 2016 has been another amazing year for Stockholm’s startup scene. Interest and investments into Stockholm tech companies continued to rise, with nearly three times as many investments in 2016 than the previous year. Stockholm-Uppsala joins forces to attract EMA The Stockholm-Uppsala region has already made the future investments to which the European Medicines Agency (EMA) requires access in order for the EU to resume its leading international position in life science. The below debate article was published in Swedish media Dagens Samhälle under the headline “Seize the Brexit effect and attract EMA”. All news STOCKHOLM ONCOLOGY SUMMARY REPORT Relevant links Health Tech Report (.pdf, 646 kB) Infectious Diseases (.pdf, 16.6 MB) Stockholm Oncology Summary Report (.pdf, 2.5 MB) Stockholm Stemcell Research (.pdf, 696 kB) Stockholm Science City Uppsala Bio Flemingsberg Science Biovation Park Kista Science Park THE LIFE SCIENCE HOTLIST A carefully selected list of investment cases from the Stockholm-Uppsala Life science sector. Åsa Andersson, Ph.D. Consultant/ Medical advisor Life Science Phone: +46 (0) 70 472 8048 Mobile: +46 (0) 8 508 28048 E-mail: asa.andersson@extern.stockholm.se Invest Stockholm Business Region AB City of Stockholm Visiting adress: Drottninggatan 33 Box 16282, 103 25 Stockholm, Sweden Phone: +46 (0)8 508 280 00 E-mail: invest@stockholm.se Facebook Twitter Linkedin Back to top